• OPEN AN ACCOUNT
Indian Indices
Sensex
81,537.70 -769.67
( -0.94%)
Global Indices
Nasdaq
49,128.98 -276.04
(-0.56%)
Dow Jones
6,938.97 4.62
(0.07%)
Hang Seng
53,831.56 142.67
(0.27%)
Nikkei 225
10,138.52 -11.53
(-0.11%)
Forex
USD-INR
91.58 0.09
(0.10%)
EUR-INR
107.27 0.14
(0.13%)
GBP-INR
123.20 0.33
(0.27%)
JPY-INR
0.58 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Hybrid Financial Services Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
500262
INE965B01022
3.8467631
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HYBRIDFIN
37.92
55.81
EPS(TTM)
Face Value()
Div & Yield %
0.5
5
0
 

Indo US Bio-Tech standalone net profit declines 40.59% in the December 2025 quarter
Jan 21,2026
Net profit of Indo US Bio-Tech declined 40.59% to Rs 3.00 crore in the quarter ended December 2025 as against Rs 5.05 crore during the previous quarter ended December 2024. Sales declined 3.23% to Rs 22.80 crore in the quarter ended December 2025 as against Rs 23.56 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales22.8023.56 -3
OPM %18.2023.47 -
PBDT3.395.17 -34
PBT3.175.01 -37
NP3.005.05 -41